Noveris Health Sciences is trading at CA$0.07, down -6.67%, with no specific catalyst identified.
- No new company-specific announcement for September 21, 2026 was identified; the latest reported item was the September 9 annual and special meeting results.
- Broader markets are firmly higher, so the decline does not align with today’s broad risk-on move.
- Available evidence does not establish a reliable reason for the drop.